BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 36902036)

  • 1. Tumor Necrosis Factor Family Members and Myocardial Ischemia-Reperfusion Injury: State of the Art and Therapeutic Implications.
    Galeone A; Grano M; Brunetti G
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia.
    Jeremias I; Kupatt C; Martin-Villalba A; Habazettl H; Schenkel J; Boekstegers P; Debatin KM
    Circulation; 2000 Aug; 102(8):915-20. PubMed ID: 10952962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulated cell death in myocardial ischemia-reperfusion injury.
    Xiang Q; Yi X; Zhu XH; Wei X; Jiang DS
    Trends Endocrinol Metab; 2024 Mar; 35(3):219-234. PubMed ID: 37981501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic derangement in ischemic heart disease and its therapeutic control.
    Ferrari R; Pepi P; Ferrari F; Nesta F; Benigno M; Visioli O
    Am J Cardiol; 1998 Sep; 82(5A):2K-13K. PubMed ID: 9737480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The receptor for activated complement factor 5 (C5aR) conveys myocardial ischemic damage by mediating neutrophil transmigration.
    Mueller M; Herzog C; Larmann J; Schmitz M; Hilfiker-Kleiner D; Gessner JE; Theilmeier G
    Immunobiology; 2013 Sep; 218(9):1131-8. PubMed ID: 23642836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial ischemia and reperfusion injury.
    Buja LM
    Cardiovasc Pathol; 2005; 14(4):170-5. PubMed ID: 16009313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen improves cardiac recovery after ischemia/reperfusion by decreasing tumor necrosis factor-alpha.
    Xu Y; Arenas IA; Armstrong SJ; Plahta WC; Xu H; Davidge ST
    Cardiovasc Res; 2006 Mar; 69(4):836-44. PubMed ID: 16403479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanisms of myocardial cell protection from ischemia/reperfusion injury and potential clinical implications].
    Lamendola P; Di Monaco A; Barone L; Pisanello C; Lanza GA; Crea F
    G Ital Cardiol (Rome); 2009 Jan; 10(1):28-36. PubMed ID: 19292017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor 3 plays a role in myocardial infarction and ischemia/reperfusion injury.
    Lu C; Ren D; Wang X; Ha T; Liu L; Lee EJ; Hu J; Kalbfleisch J; Gao X; Kao R; Williams D; Li C
    Biochim Biophys Acta; 2014 Jan; 1842(1):22-31. PubMed ID: 24140513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-alpha content and enhancing prostaglandin release.
    Calabresi L; Rossoni G; Gomaraschi M; Sisto F; Berti F; Franceschini G
    Circ Res; 2003 Feb; 92(3):330-7. PubMed ID: 12595346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluvastatin attenuated ischemia/reperfusion-induced autophagy and apoptosis in cardiomyocytes through down-regulation HMGB1/TLR4 signaling pathway.
    Ding HS; Yang J; Yang J; Guo X; Tang YH; Huang Y; Chen Z; Fan ZX; Huang CX
    Mol Biol Rep; 2021 May; 48(5):3893-3901. PubMed ID: 34032975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic disarrangement in ischemic heart disease and its therapeutic control.
    Ferrari R
    Rev Port Cardiol; 1998 Sep; 17(9):667-84. PubMed ID: 9834638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased myocardial tumor necrosis factor-alpha in a crystalloid-perfused model of cardiac ischemia-reperfusion injury.
    Meldrum DR; Cleveland JC; Cain BS; Meng X; Harken AH
    Ann Thorac Surg; 1998 Feb; 65(2):439-43. PubMed ID: 9485242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF-α antagonism ameliorates myocardial ischemia-reperfusion injury in mice by upregulating adiponectin.
    Gao C; Liu Y; Yu Q; Yang Q; Li B; Sun L; Yan W; Cai X; Gao E; Xiong L; Wang H; Tao L
    Am J Physiol Heart Circ Physiol; 2015 Jun; 308(12):H1583-91. PubMed ID: 25888509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced research on the regulated necrosis mechanism in myocardial ischemia-reperfusion injury.
    Deng J
    Int J Cardiol; 2021 Jul; 334():97-101. PubMed ID: 33930510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus.
    Lejay A; Fang F; John R; Van JA; Barr M; Thaveau F; Chakfe N; Geny B; Scholey JW
    J Mol Cell Cardiol; 2016 Feb; 91():11-22. PubMed ID: 26718721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen gas inhalation alleviates myocardial ischemia-reperfusion injury by the inhibition of oxidative stress and NLRP3-mediated pyroptosis in rats.
    Nie C; Ding X; A R; Zheng M; Li Z; Pan S; Yang W
    Life Sci; 2021 May; 272():119248. PubMed ID: 33621592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HMGB1-TLR4 axis contributes to myocardial ischemia/reperfusion injury via regulation of cardiomyocyte apoptosis.
    Ding HS; Yang J; Chen P; Yang J; Bo SQ; Ding JW; Yu QQ
    Gene; 2013 Sep; 527(1):389-93. PubMed ID: 23727604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in infarct size by ischemic preconditioning persists in a chronic rat model of myocardial ischemia-reperfusion injury.
    Lott FD; Guo P; Toombs CF
    Pharmacology; 1996 Feb; 52(2):113-8. PubMed ID: 8851632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.